Sosei Group has been granted a patent for compounds that act as agonists of the muscarinic M1 and M4 receptors. These compounds are intended for treating various conditions, including cognitive and psychotic disorders, pain, addiction, and movement disorders, through specific pharmaceutical compositions. GlobalData’s report on Sosei Group gives a 360-degree view of the company including its patenting strategy. Buy the report here.
Smarter leaders trust GlobalData
According to GlobalData’s company profile on Sosei Group, was a key innovation area identified from patents. Sosei Group's grant share as of June 2024 was 32%. Grant share is based on the ratio of number of grants to total number of patents.
The granted patent US12024499B2 outlines a method for treating various disorders, including cognitive and psychotic disorders, as well as different types of pain such as acute, chronic, neuropathic, and inflammatory pain. The method involves administering an effective amount of a specific compound, denoted as formula (1). The claims specify that the compound can be selected from a group of chemical entities, which include various ethyl derivatives of 6-azaspiro[3.4]octane-6-carboxylate, each containing a piperidine moiety and differing in their azetidine substituents. Additionally, the claims allow for the use of pharmaceutically acceptable salts of these compounds.
Further details in the claims indicate that the compound may be administered in a pharmaceutical composition that includes the active compound or its salt, combined with a pharmaceutically acceptable excipient. The claims also specify variations in the substituent R4, which can be either hydrogen or methyl. This patent provides a framework for the potential therapeutic applications of these compounds in treating a range of disorders, highlighting their versatility in addressing both psychological and physical health issues.
To know more about GlobalData’s detailed insights on Sosei Group, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies
